SCCM Podcast

William Dager, PharmD, and John S. MacGregor, MD, PhD, discuss an article in the December 2006 issue of Critical Connections, titled "Recent Advances in Cardiology Pharmacotherapies for the ICU Clinician." The article was written by Joseph Dasta, PharmD, from The Ohio State University, and Jaclyn LeBlanc, PharmD, BCPS, from The University of Oklahoma. Dr. Dager is a pharmacist specialist at UC Davis Medical Center and a clinical professor of pharmacy at UC San Francisco School of Pharmacy. Dr. MacGregor is a professor of medicine in the division of cardiology at the University of California San Francisco Medical Center and is director of the cardiac catheterization laboratory at San Francisco General Hospital.

Stanley Nasraway, MD, FCCM, discuss an article in the December issue of Critical Care Medicine "Heparin-induced Thuombocytopenia in the critical care setting: Diagnosis and management." The reference is Critical Care Medicine. 2006 34(12):2898-2911. This article offers continuing medical educational credit.

The Society of Critical Care Medicine's eNewsletter provides members of the critical care community with vital news relevant to their practice as well as updates on Society activities and programs.

Eric Pacht, MD, discuss an editorial published in the September issue of Critical Care Medicine, "Enteral therapy to decrease morbidity and improve survival in acute respiratory distress syndrome: Its time has come." Dr. Pacht is a pulmonary and critical care specialist and the director of the intensive care unit at Licking Memorial Hospital in Ohio. (Crit Care Med; 2006 34(9):2292-2493)

Saraswati Dayal, MD, and Edwin Deitch, MD, discuss an article published in the September issue of Critical Care Medicine, "ICU management of the trauma patient.." The review examines closely the most important intensive care unit issues and approaches unique to trauma patients. Dr. Dayal is an attending in trauma and surgical critical care at Hacksensack University Memorial Center in New Jersey. Dr. Deitch is professor and chairman of the department of surgery at the New Jersey Medical School of the University of Medicine and Dentistry of New Jersey. (Crit Care Med; 2006 34(9):2294-2301)

Yizhak Kupfer, MD, discusses his lecture, to be held during the 36th Critical Care Congress, "Reduction of Medication Errors in the Intensive Care Unit." Dr. Kupfer is an associate professor of medicine at SUNY Downstate School of Medicine and is the director of the medical intensive care unit at Maimonides Medical Center in New York, New York.

The Society of Critical Care Medicine's eNewsletter provides members of the critical care community with vital news relevant to their practice as well as updates on Society activities and programs.

Derek Angus, MD, MPH, discusses a new, multicenter research consortium, called Protocolized Care for Early Septic Shock (ProCESS). The consortium is beginning a large-scale study to determine whether specific interventions can halt the progression to severe sepsis and septic shock. Dr. Angus along with SCCM members Mitchell Fink, MD, and Donald Yealy, MD, will lead a team of intensive care unit and emergency department personnel. The study is likely to offer valuable insight on the best ways to treat sepsis and the value of early goal-directed therapy. Dr. Angus is vice chairman of research for the University of Pittsburgh School of Medicine's critical care department.

Simon Finfer, MD, MBBS, MRCP, is one of the prominent keynote speakers set to present during the 36th Critical Care Congress February 17 to 21, 2007. He discusses his keynote presentation "The Clinical Role of Albumin in the Critically Ill" as well as his latest critical care endeavors. Dr. Fifner is a senior staff specialist in intensive care at Royal North Shore Hospital of Sydney. Dr Finfer received his training from London University and Westminster Medical School, London University. He also trained in pediatric intensive care at the world-renowned Hospital for Sick Children in Toronto, Canada.

Mitchell Levy, MD, FCCM, discusses a perspectives article published in the October 19, 2006, issue of the New England Journal of Medicine, titled Surviving Sepsis-Practice Guidelines, Marketing Campaigns, and Eli Lilly, which criticizes the campaign and its major funding source, Eli Lilly.